Exhibitor Product Theater - The Power of the Microbiome: Can it be harnessed to break the cycle of recurrent Clostridioides difficile infection (rCDI)?

Paul Feuerstadt, MD, FACG

This program is sponsored by Ferring Pharmaceuticals, Inc.

Understand the role of the microbiome in overall health and the essential, symbiotic roles of Bacteroidetes and Firmicutes • Explore the relationship between the gut microbiome, pathogenesis of Clostridioides difficile infection (CDI), and the cycle of recurrence • Describe the profound burden of rCDI during and beyond acute infection • Evaluate the potential of microbiome-based therapeutics in the management of rCDI.

Open to all ACG 2022 attendees, industry-sponsored Product Theater provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibit Product Theater presentations.